Dr. Androniki Raftogianni is an Assistant Professor of Physiology of Behavior (Neuroscience) in the Department of Psychology at the University of Crete, Greece. She received her Ph.D. in Neuroscience from the National and Kapodistrian University of Athens in 2013, where she investigated how experiences during critical developmental periods, including the neonatal period and adolescence, shape brain development, stress responsiveness, emotional regulation, and social behavior later in life. She subsequently completed postdoctoral training at the Max Planck Institute for Medical Research and the German Cancer Research Center (DKFZ), affiliated with Heidelberg University, Germany, where she investigated the role of oxytocin and other neuropeptides in regulating stress, fear, and social behavior using optogenetic and chemogenetic approaches. Her research integrates behavioral, molecular, cellular, and circuit neuroscience to understand brain development, stress resilience, emotional regulation, and social behavior. She has authored numerous peer-reviewed publications, secured competitive research funding, and received national and international awards. Dr. Raftogianni is currently a Board Member of the Hellenic Society for Neuroscience, previously served as Treasurer until 2023, and served three terms as a Board Member of the European Brain and Behaviour Society (EBBS), most recently 2023–2025. She also serves as an editor and reviewer for international neuroscience journals.
Dr. Androniki Raftogianni is an Assistant Professor of Physiology of Behavior (Neuroscience) in the Department of Psychology at the University of Crete, Greece. She received her Ph.D. in Neuroscience from the National and Kapodistrian University of Athens in 2013, where she investigated how experiences during critical developmental periods, including the neonatal period and adolescence, shape brain development, stress responsiveness, emotional regulation, and social behavior later in life. She subsequently completed postdoctoral training at the Max Planck Institute for Medical Research and the German Cancer Research Center (DKFZ), affiliated with Heidelberg University, Germany, where she investigated the role of oxytocin and other neuropeptides in regulating stress, fear, and social behavior using optogenetic and chemogenetic approaches. Her research integrates behavioral, molecular, cellular, and circuit neuroscience to understand brain development, stress resilience, emotional regulation, and social behavior. She has authored numerous peer-reviewed publications, secured competitive research funding, and received national and international awards. Dr. Raftogianni is currently a Board Member of the Hellenic Society for Neuroscience, previously served as Treasurer until 2023, and served three terms as a Board Member of the European Brain and Behaviour Society (EBBS), most recently 2023–2025. She also serves as an editor and reviewer for international neuroscience journals.